{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T15:01:48Z","timestamp":1778770908712,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Imaging"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s40644-017-0109-5","type":"journal-article","created":{"date-parts":[[2017,2,16]],"date-time":"2017-02-16T15:42:29Z","timestamp":1487259749000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Crizotinib Associated Renal Cysts [CARCs]: incidence and patterns of evolution"],"prefix":"10.1186","volume":"17","author":[{"given":"Laird B","family":"Cameron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damian H S","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Moodie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bimal Kumar","family":"Parameswaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,16]]},"reference":[{"issue":"7153","key":"109_CR1","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","volume":"448","author":"M Soda","year":"2007","unstructured":"Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S, et al. Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer. Nature. 2007;448(7153):561\u20136.","journal-title":"Nature"},{"issue":"12","key":"109_CR2","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1097\/JTO.0b013e3181c4dedb","volume":"4","author":"B Solomon","year":"2009","unstructured":"Solomon B, Varella-Garcia M, Camidge DR. ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancer. J Thorac Oncol. 2009;4(12):1450\u20134.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"109_CR3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S1470-2045(12)70344-3","volume":"13","author":"DR Camidge","year":"2012","unstructured":"Camidge DR, Bang YJ, Kwak EL, Iafrate AJ, Varella-Garcia M, Fox SB, et al. Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study. Lancet Oncol. 2012;13(10):1011\u20139.","journal-title":"Lancet Oncol"},{"key":"109_CR4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1200\/jco.2014.32.15_suppl.8001","volume":"32","author":"D Camidge","year":"2014","unstructured":"Camidge D, Ou S, Shapiro G, Otterson G, Villaruz L, Villalona-Calero M, et al. Efficacy and safety of crizotinib in patients with advanced c-MET-amplified non-small cell lung cancer (NSCLC). J Clin Oncol. 2014;32:15.","journal-title":"J Clin Oncol"},{"key":"109_CR5","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1056\/NEJMoa1406766","volume":"371","author":"AT Shaw","year":"2014","unstructured":"Shaw AT, Ou S-HI, Bang Y-J, Camidge DR, Solomon BJ, Salgia R, et al. Crizotinib in ROS1-Rearranged Non\u2013Small-Cell Lung Cancer. N Engl J Med. 2014;371:1963\u201371.","journal-title":"N Engl J Med"},{"issue":"23","key":"109_CR6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1056\/NEJMoa1408440","volume":"371","author":"BJ Solomon","year":"2014","unstructured":"Solomon BJ, Mok T, Kim D-W, Wu Y-L, Nakagawa K, Mekhail T, et al. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer. N Engl J Med. 2014;371(23):2167\u201377.","journal-title":"N Engl J Med"},{"issue":"2","key":"109_CR7","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/annonc\/mdt572","volume":"25","author":"SH Ou","year":"2014","unstructured":"Ou SH, Janne PA, Bartlett CH, Tang Y, Kim DW, Otterson GA, et al. Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC. Ann Oncol. 2014;25(2):415\u201322.","journal-title":"Ann Oncol"},{"key":"109_CR8","unstructured":"FDA. Crizotinib Label. http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2013\/202570s006lbl.pdf ."},{"issue":"11","key":"109_CR9","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1097\/JTO.0000000000000326","volume":"9","author":"Y-T Lin","year":"2014","unstructured":"Lin Y-T, Wang Y-F, Yang JC-H, Yu C-J, Wu S-G, Shih J-Y, et al. Development of renal cysts after crizotinib treatment in advanced ALK-positive non\u2013small-cell lung cancer. J Thoracic Oncol. 2014;9(11):1720\u20135.","journal-title":"J Thoracic Oncol"},{"key":"109_CR10","doi-asserted-by":"crossref","unstructured":"Schnell P, Bartlett CH, Solomon BJ, Tassell V, Shaw AT, Pas T et al. Complex renal cysts associated with crizotinib treatment. Cancer Med. 2015;4(6):887\u201396.","DOI":"10.1002\/cam4.437"},{"issue":"9","key":"109_CR11","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1634\/theoncologist.2014-0216","volume":"19","author":"SJ Klempner","year":"2014","unstructured":"Klempner SJ, Aubin G, Dash A, Ou S. Spontaneous regression of crizotinib-associated complex renal cysts during continuous crizotinib treatment. Oncologist. 2014;19(9):1008\u201310.","journal-title":"Oncologist"},{"issue":"3","key":"109_CR12","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00256861","volume":"5","author":"L Baert","year":"1977","unstructured":"Baert L, Steg A. On the pathogenesis of simple renal cysts in the adult. A microdissection study. Urol Res. 1977;5(3):103\u20138.","journal-title":"Urol Res"},{"key":"109_CR13","doi-asserted-by":"crossref","unstructured":"Carrim ZI, Murchison JT. The prevalence of simple renal and hepatic cysts detected by spiral computed tomography. Clin Radiol. 2003;58:626\u201329.","DOI":"10.1016\/S0009-9260(03)00165-X"},{"issue":"1","key":"109_CR14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.urology.2007.07.075","volume":"71","author":"N Terada","year":"2008","unstructured":"Terada N, Arai Y, Kinukawa N, Terai A. The 10-year natural history of simple renal cysts. Urology. 2008;71(1):7\u201311.","journal-title":"Urology"},{"issue":"7","key":"109_CR15","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1464-410X.2005.05442.x","volume":"95","author":"KS Warren","year":"2005","unstructured":"Warren KS, McFarlane J. The Bosniak classification of renal cystic masses. BJU Int. 2005;95(7):939\u201342.","journal-title":"BJU Int"},{"issue":"2","key":"109_CR16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.5489\/cuaj.10023","volume":"4","author":"TF Whelan","year":"2010","unstructured":"Whelan TF. Guidelines on the management of renal cyst disease. Can Urol Assoc J. 2010;4(2):98\u20139.","journal-title":"Can Urol Assoc J"},{"issue":"2","key":"109_CR17","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2214\/ajr.175.2.1750339","volume":"175","author":"NS Curry","year":"2000","unstructured":"Curry NS, Cochran ST, Bissada NK. Cystic renal masses: accurate Bosniak classification requires adequate renal CT. AJR Am J Roentgenol. 2000;175(2):339\u201342.","journal-title":"AJR Am J Roentgenol"},{"key":"109_CR18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4236\/alc.2015.44007","volume":"4","author":"L Carvalho de","year":"2015","unstructured":"de Carvalho L, Shimada A, da Cruz Neto M, da Silva Rocha L, Viana P, Kallas E, Katz A. Development of aseptic renal abscess in a patient with non-small-cell lung cancer with ALK translocation during Crizotinib treatment. Adv Lung Cancer. 2015;4:53\u20137.","journal-title":"Adv Lung Cancer"},{"issue":"3","key":"109_CR19","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.radcr.2016.04.010","volume":"11","author":"WY Chan","year":"2016","unstructured":"Chan WY, Ang MK, Tan DS, Koh WL, Kwek JW. Imaging features of renal complications after crizotinib treatment for non-small-cell lung cancer: a case report. Radiol Case Rep. 2016;11(3):245\u20137.","journal-title":"Radiol Case Rep"},{"key":"109_CR20","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s10637-014-0195-1","volume":"33","author":"Y Yoneshima","year":"2015","unstructured":"Yoneshima Y, Okamoto I, Arimura-Omori M, Kimura S, Hidaka-Fujimoto N, Iwama E. Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangement. Invest New Drugs. 2015;33:510\u20132.","journal-title":"Invest New Drugs"},{"key":"109_CR21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13045-016-0251-8","volume":"9","author":"J Wu","year":"2016","unstructured":"Wu J, Savooji J, Liu D. Second- and third-generation ALK inhibitors for non-small cell lung cancer. J Hematol Oncol. 2016;9:19.","journal-title":"J Hematol Oncol"},{"issue":"8925","key":"109_CR22","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0140-6736(94)92344-2","volume":"344","author":"S Horie","year":"1994","unstructured":"Horie S, Higashihara E, Nutahara K, Mikami Y, Okubo A, Kano M, et al. Mediation of renal cyst formation by hepatocyte growth factor. Lancet. 1994;344(8925):789\u201391.","journal-title":"Lancet"},{"issue":"9","key":"109_CR23","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1093\/jn\/130.9.2356","volume":"130","author":"S Jayapalan","year":"2000","unstructured":"Jayapalan S, Saboorian MH, Edmunds JW, Aukema HM. High dietary fat intake increases renal cyst disease progression in Han: SPRD-cy rats. J Nutr. 2000;130(9):2356\u201360.","journal-title":"J Nutr"},{"issue":"2","key":"109_CR24","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0272-6386(97)90039-1","volume":"29","author":"BD Cowley Jr","year":"1997","unstructured":"Cowley Jr BD, Rupp JC, Muessel MJ, Gattone 2nd VH. Gender and the effect of gonadal hormones on the progression of inherited polycystic kidney disease in rats. Am J Kidney Dis. 1997;29(2):265\u201372.","journal-title":"Am J Kidney Dis"},{"issue":"21","key":"109_CR25","doi-asserted-by":"crossref","first-page":"5302","DOI":"10.1002\/cncr.27450","volume":"118","author":"AJ Weickhardt","year":"2012","unstructured":"Weickhardt AJ, Rothman MS, Salian-Mehta S, Kiseljak-Vassiliades K, Oton AB, Doebele RC, et al. Rapid-onset hypogonadism secondary to crizotinib use in men with metastatic nonsmall cell lung cancer. Cancer. 2012;118(21):5302\u20139.","journal-title":"Cancer"}],"container-title":["Cancer Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40644-017-0109-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T19:37:20Z","timestamp":1568835440000},"score":1,"resource":{"primary":{"URL":"http:\/\/cancerimagingjournal.biomedcentral.com\/articles\/10.1186\/s40644-017-0109-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,16]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["109"],"URL":"https:\/\/doi.org\/10.1186\/s40644-017-0109-5","relation":{},"ISSN":["1470-7330"],"issn-type":[{"value":"1470-7330","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,16]]},"article-number":"7"}}